MDS Virtual Congress 2020 Archives - Page 69 of 149

Identifying de novo Parkinson’s disease with optical coherence tomography of the retina: A machine learning classification approach

A. Chrysou, T. Heikka, S. Vander Zee, J. Boertien, N. Jansonius, T. van Laar (Groningen, Netherlands)
Identifying neural signatures of Parkinson’s disease that predict decline in gait and postural control

H. Sigurdsson, A. Yarnall, B. Galna, S. Lord, L. Alcock, R. Morris, R. Lawson, S. Colloby, M. Firbank, N. Pavese, D. Brooks, J. O'brien, D. Burn, L. Rochester (Newcastle upon Tyne, United Kingdom)
Identifying Neuropsychiatric Profiles in Parkinson’s disease, Dementia with Lewy Bodies and Alzheimer’s disease

D. Smith, P. Donaghy, B. Galna, A. Yarnall, J.P Taylor, D. Burn, A. Thomas, L. Rochester, R. Mc Ardle, R. Lawson (Newcastle upon Tyne, United Kingdom)
Identifying the functional brain network of motor reserve in early Parkinson’s disease

S.J Chung, H.R Kim, J.H Jung, P.H Lee, Y. Jeong, Y.H Sohn (Seoul, Republic of Korea)
Idiopathic cervical dystonia – does autoimmunity play a hand?

A. Panwar, N. Sawal, D. Garg, R. Kaur (Chandigarh, India)
Idiopathic Upper Limb Dystonia – Time for a better understanding

T. Ercoli, R. Pellicciari, G. Fabbrini, G. Ferrazzano, MM. Mascia, R. Eleopra, A. Albanese, R. Erro, P. Barone, L. Avanzino, R. Ceravolo, M. Esposito, L. Bertolasi, C. Scaglione, A.R Bentivoglio, M.C Altavista, F. Bono, P. Girlanda, A. Pisani, M.S Cotelli, B. Minafra, A. Castagna, M. Zibetti, S. Misceo, L. Magistrelli, G. Cossu, M. Coletti Moja, A. Berardelli, G. Defazio (Cagliari, Italy)
Impact of Chronotypes and melatonin levels on sleep disorders in patients with Parkinson’s disease

R. Borgohain, M. Voodi, R. Kandadai, S. Meka, T. Syed, S. Turaga (Hyderabad, India)
Impact of community boxing program on motor impairments of Parkinson’s Disease (PD) including: gait, functional mobility, dual task and coordination

S. Shearin, M. Braitsch, R. Querry (Dallas, TX, USA)
Impact of Deep Brain Stimulation on Fall Risk

K. Lyons, V. Pahwa, R. Pahwa (Kansas City, KS, USA)
Impact of dopamine 2/3 receptor agonists on the phenomenology of L-DOPA-induced dyskinesia in patients with Parkinson’s disease

S. Grigoriou, S. Christiansson, P. Odin, M.A Cenci (Lund, Sweden)